Faron Liabilities And Stockholders Equity from 2010 to 2024
| FARN Stock | 165.00 10.00 5.71% |
Liabilities And Stockholders Equity | First Reported 2014-03-31 | Previous Quarter 35.5 M | Current Value 35.5 M | Quarterly Volatility 7 M |
Check Faron Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Faron Pharmaceuticals' main balance sheet or income statement drivers, such as Depreciation And Amortization of 185.2 K, Interest Expense of 2.3 M or Selling General Administrative of 9.1 M, as well as many indicators such as . Faron financial statements analysis is a perfect complement when working with Faron Pharmaceuticals Valuation or Volatility modules.
Faron | Liabilities And Stockholders Equity |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Faron Stock Analysis
When running Faron Pharmaceuticals' price analysis, check to measure Faron Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Faron Pharmaceuticals is operating at the current time. Most of Faron Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Faron Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Faron Pharmaceuticals' price. Additionally, you may evaluate how the addition of Faron Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.